Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Long-Chain Acyl Coenzyme A Synthetase 1 Overexpression in Primary Cultured
Schwann Cells Prevents Long Chain Fatty Acid-Induced Oxidative Stress and
Mitochondrial Dysfunction.
Authors
Hinder LM, Figueroa-Romero C, Pacut C, Hong Y, Vivekanandan-Giri A, Pennathur S,
Feldman EL
Submitted By
Eva Feldman on 4/15/2014
Status
Published
Journal
Antioxidants & redox signaling
Year
2013
Date Published
10/5/2013
Volume : Pages
21 : 588 - 600
PubMed Reference
23991914
Abstract
Abstract Aims: High circulating long chain fatty acids (LCFAs) are implicated in
diabetic neuropathy (DN) development. Expression of the long-chain acyl-CoA
synthetase 1 (Acsl1) gene, a gene required for LCFA metabolic activation, is
altered in human and mouse diabetic peripheral nerve. We assessed the
significance of Acsl1 upregulation in primary cultured Schwann cells. Results:
Acsl1 overexpression prevented oxidative stress (nitrotyrosine;
hydroxyoctadecadienoic acids [HODEs]) and attenuated cellular injury (TUNEL) in
Schwann cells following 12?h exposure to LCFAs (palmitate, linoleate, and
oleate, 100?µM). Acsl1 overexpression potentiated the observed increase in
medium to long-chain acyl-carnitines following 12?h LCFA exposure. Data are
consistent with increased mitochondrial LCFA uptake, largely directed to
incomplete beta-oxidation. LCFAs uncoupled mitochondrial oxygen consumption from
ATP production. Acsl1 overexpression corrected mitochondrial dysfunction,
increasing coupling efficiency and decreasing proton leak. Innovation: Schwann
cell mitochondrial function is critical for peripheral nerve function, but
research on Schwann cell mitochondrial dysfunction in response to hyperlipidemia
is minimal. We demonstrate that high levels of a physiologically relevant
mixture of LCFAs induce Schwann cell injury, but that improved mitochondrial
uptake and metabolism attenuate this lipotoxicity. Conclusion: Acsl1
overexpression improves Schwann cell function and survival following high LCFA
exposure in vitro; however, the observed endogenous Acsl1 upregulation in
peripheral nerve in response to diabetes is not sufficient to prevent the
development of DN in murine models of DN. Therefore, targeted improvement in
Schwann cell metabolic disposal of LCFAs may improve DN phenotypes. Antioxid.
Redox Signal. 00, 000-000.
Investigators with authorship
Name
Institution
Eva Feldman
University of Michigan
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!